Trial Profile
A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy.
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Male osteoporosis
- Focus Therapeutic Use
- Sponsors Novartis; Novartis Pharmaceuticals
- 09 Oct 2009 New trial record